160 related articles for article (PubMed ID: 37110369)
1. Multidrug Resistance in Critically Ill Patients: An Unresolved Issue.
Spadaro S
Microorganisms; 2023 Apr; 11(4):. PubMed ID: 37110369
[TBL] [Abstract][Full Text] [Related]
2. Optimizing Antimicrobial Drug Dosing in Critically Ill Patients.
Póvoa P; Moniz P; Pereira JG; Coelho L
Microorganisms; 2021 Jun; 9(7):. PubMed ID: 34203510
[TBL] [Abstract][Full Text] [Related]
3. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
4. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
Pugh R; Grant C; Cooke RP; Dempsey G
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007577. PubMed ID: 26301604
[TBL] [Abstract][Full Text] [Related]
5. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
[TBL] [Abstract][Full Text] [Related]
6. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit.
Becher RD; Hoth JJ; Rebo JJ; Kendall JL; Miller PR
Surg Infect (Larchmt); 2012 Dec; 13(6):352-9. PubMed ID: 23268613
[TBL] [Abstract][Full Text] [Related]
7. [Chinese expert consensus on the management of lower respiratory tract infections of
Pulmonary Infection Assembly of Chinese Thoracic Society
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):739-752. PubMed ID: 35927044
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Multidrug Resistance: Clinical Implications for Infection Management in Critically Ill Patients.
Kalın G; Alp E; Chouaikhi A; Roger C
Microorganisms; 2023 Oct; 11(10):. PubMed ID: 37894233
[TBL] [Abstract][Full Text] [Related]
9. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.
Dellinger RP; Levy MM; Rhodes A; Annane D; Gerlach H; Opal SM; Sevransky JE; Sprung CL; Douglas IS; Jaeschke R; Osborn TM; Nunnally ME; Townsend SR; Reinhart K; Kleinpell RM; Angus DC; Deutschman CS; Machado FR; Rubenfeld GD; Webb SA; Beale RJ; Vincent JL; Moreno R;
Crit Care Med; 2013 Feb; 41(2):580-637. PubMed ID: 23353941
[TBL] [Abstract][Full Text] [Related]
10. Optimal aminoglycoside therapy following the sepsis: how much is too much?
Mahmoudi L; Niknam R; Mousavi S; Ahmadi A; Honarmand H; Ziaie S; Mojtahedzadeh M
Iran J Pharm Res; 2013; 12(2):261-9. PubMed ID: 24250599
[TBL] [Abstract][Full Text] [Related]
11. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
12. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
13. Trauma and Antimicrobial Resistance Are Independent Predictors of Inadequate Empirical Antimicrobial Treatment of Ventilator-Associated Pneumonia in Critically Ill Patients.
Jovanovic B; Djuric O; Hadzibegovic A; Jovanovic S; Stanisavljevic J; Milenkovic M; Rajkovic M; Ratkovic S; Markovic-Denic L
Surg Infect (Larchmt); 2021 Sep; 22(7):730-737. PubMed ID: 33439780
[No Abstract] [Full Text] [Related]
14. Bloodstream infections in critically ill patients: an expert statement.
Timsit JF; Ruppé E; Barbier F; Tabah A; Bassetti M
Intensive Care Med; 2020 Feb; 46(2):266-284. PubMed ID: 32047941
[TBL] [Abstract][Full Text] [Related]
15. Multidrug-resistant pathogens and pneumonia: comparing the trauma and surgical intensive care units.
Becher RD; Hoth JJ; Neff LP; Rebo JJ; Martin RS; Miller PR
Surg Infect (Larchmt); 2011 Aug; 12(4):267-72. PubMed ID: 21524206
[TBL] [Abstract][Full Text] [Related]
16. Update of the treatment of nosocomial pneumonia in the ICU.
Zaragoza R; Vidal-Cortés P; Aguilar G; Borges M; Diaz E; Ferrer R; Maseda E; Nieto M; Nuvials FX; Ramirez P; Rodriguez A; Soriano C; Veganzones J; Martín-Loeches I
Crit Care; 2020 Jun; 24(1):383. PubMed ID: 32600375
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.
Campion M; Scully G
J Intensive Care Med; 2018 Dec; 33(12):647-655. PubMed ID: 29534630
[TBL] [Abstract][Full Text] [Related]
18. Optimal duration of antimicrobial therapy in ventilator-associated pneumonia: What is the role for procalcitonin?
Pinzone MR; Cacopardo B; Abbo L; Nunnari G
J Glob Antimicrob Resist; 2014 Dec; 2(4):239-244. PubMed ID: 27873682
[TBL] [Abstract][Full Text] [Related]
19. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
Barbier F; Andremont A; Wolff M; Bouadma L
Curr Opin Pulm Med; 2013 May; 19(3):216-28. PubMed ID: 23524477
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
